Results 161 to 170 of about 377,839 (219)

Duration of vaccine-induced immunity following MMR2 vaccination in a measles and rubella-eliminated country. [PDF]

Int J Epidemiol
Chun JY, Kim AR, Jeong H, Kim YJ, Kang HJ, Jeong HS, Rhie GE, Jee Y, Kim Y, Lee J.   +9 more
europepmc   +1 more source

Surveillance and analysis of adverse events following immunization (AEFI) with measles, mumps, and rubella (MMR) vaccine in Zhejiang Province, China, 2020-2025. [PDF]

Front Public Health
Pan X, Chen Y, He H, Qi X, Shen L, Liang H.   +5 more
europepmc   +1 more source

Measles-Containing Vaccine Use for Children Aged 12 to 47 Months, 2015 to 2025.

JAMA Netw Open
Fagalde MS, Page LC, Marder EP, Shim MM, Bogan S, Patel D, Kay MK, Chow EJ.   +7 more
europepmc   +1 more source

Meningitis associated with measles-mumps-rubella vaccines.

Releve epidemiologique hebdomadaire, 1992
openaire   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Combined Vaccine Against Measles, Mumps, Rubella, and Varicella

Pediatrics, 1988
A combined measles, mumps, rubella, and varicella vaccine produced seroconversions for all four components similar to that found if measles, mumps, and rubella vaccine or live varicella vaccine were given separately. In addition, those exposed to varicella were completely protected or had only a mild rash.
P A, Brunell, V M, Novelli, S V, Lipton, B, Pollock   +3 more
exaly   +3 more sources